Pralsetinib and its Impurities

Pralsetinib, sold under the brand name Gavreto, is a medication approved RET mutation-positive medullary thyroid cancer and RET fusion-positive differentiated thyroid cancer refractory to radioactive iodine therapy. Reference standards of Pralsetinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 4 results for Pralsetinib Impurities
PA 16 3770000

Pralsetinib

Pralsetinib

  • Catalogue No.:PA 16 3770000

  • CAS :

    2097132-94-8

  • Molecular Formula : C27H32FN9O2

  • Molecular Weight : 533.61

Enquire
Details
PA 16 3771000

(S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethan-1-amine Hydrochloride

(S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethan-1-amine Hydrochloride

  • Catalogue No.:PA 16 3771000

  • CAS :

    2097133-17-8

  • Molecular Formula : C10H12ClFN4

  • Molecular Weight : 242.68

Enquire
Details
PA 16 3771001

Methyl cis-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]cyclohexanecarboxylate

Methyl cis-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]cyclohexanecarboxylate

  • Catalogue No.:PA 16 3771001

  • CAS :

    2778223-51-9

  • Molecular Formula : C18H25N5O3

  • Molecular Weight : 359.43

Enquire
Details
PA 16 3771002

cis-1-Methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]cyclohexanecarboxylic Acid

cis-1-Methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]cyclohexanecarboxylic Acid

  • Catalogue No.:PA 16 3771002

  • CAS :

    2778223-52-0

  • Molecular Formula : C17H23N5O3

  • Molecular Weight : 345.4

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
CPHI INDIA- 28, 30 November